zentaris.com | Specialty Biopharmaceutical Company

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.zentaris.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Specialty Biopharmaceutical Company \| Aeterna
Description	Pipeline AIM Biologicals AEZS-150 AEZS-130 (Macimorelin) Macimorelin Aeterna Zentaris is a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The Company’s lead product, macimorelin, is the first and only U.S. FDA and European Commission approved oral test indicated
Keywords	N/A

Server Information

WebSite	zentaris.com
Host IP	23.236.62.147
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

zentaris.com Valuation

US$21,885,623

Last updated: 2023-04-29 10:21:16

zentaris.com has Semrush global rank of 483,619. zentaris.com has an estimated worth of US$ 21,885,623, based on its estimated Ads revenue. zentaris.com receives approximately 2,525,265 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, zentaris.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$21,885,623
Daily Ads Revenue	US$20,203
Monthly Ads Revenue	US$606,064
Yearly Ads Revenue	US$7,272,761
Daily Unique Visitors	168,351
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
zentaris.com.	A	3599	IP: 23.236.62.147
zentaris.com.	NS	3600	NS Record: ns36.domaincontrol.com.
zentaris.com.	NS	3600	NS Record: ns35.domaincontrol.com.
zentaris.com.	MX	3600	MX Record: 10 aezsinc-com.mail.protection.outlook.com.

HtmlToTextCheckTime:2023-04-29 10:21:16

top of page Pipeline AIM Biologicals AEZS-150 AEZS-130 (Macimorelin) Macimorelin Dx About About Leadership Team Board of Directors Locations Our Product Macimorelin DX Publications Our Pipeline Overview AIM Biologicals AEZS-150 AEZS-130 (Macimorelin) Macimorelin Dx Publications Clinical Studies News Investors Overview Press Releases Events Analyst Coverage Company Information Stock Data Financial Filings Corporate Governance Email Alerts Contact Therapeutic Development Pipeline Diagnostic Pipeline Aeterna is regaining rights to macimorelin (Macrilen™) in the United States and Canada in May 2023 and is engaged in robust business development efforts to identify and secure a new development and commercialization partner in these territories. LATEST NEWS Stock Info + investors Data delayed 15 minutes unless otherwise indicated Specialty Biopharmaceutical Company + Corporate Presentation + Fact Sheet + Sign up for Alerts Stay up to date on news, filings and events ©2023 Aeterna Zentaris

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Fri, 22 Oct 2021 08:47:06 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.zentaris.com/
strict-transport-security: max-age=120
Age: 45366
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=96
X-Seen-By: 6ivkWfREES4Y8b2pOpzk7CWfEJXUOf1J0Ah0dFlolkk=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVg7pplJLUdDImlJdyKbnx4u,m0j2EEknGIVUW/liY8BLLszgE+lc033b2l09xWxRjp5lstwothkaV5CJ10PE1l/n,2d58ifebGbosy5xc+FRalt2Bfo/YGvPqhlrb9oOsfZx2/YK0ClhfWOPn/KUdW6O1tPQEFK7S6DF6004SOO1fxQ==,2UNV7KOq4oGjA5+PKsX47KDzNxuUDEAOOfLloEmnHbZYgeUJqUXtid+86vZww+nL
Cache-Control: no-cache
X-Wix-Request-Id: 1634892426.21179174170635420
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Fri, 22 Oct 2021 08:47:06 GMT
content-type: text/html; charset=UTF-8
content-length: 377365
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"7b7d8e497132212587dc6ed79f3c32fd"
content-language: en-US
strict-transport-security: max-age=120
age: 216993
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=42; Max-Age=20; Expires=Tue, 19 Oct 2021 20:30:53 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YZ/puuvLe4ia6bACtvoDI2U=,jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgjB5iMgVduhJkO1xgMq9zO,m0j2EEknGIVUW/liY8BLLpKOvBhYRuLEqdCLHFrW+6dGkFvVdT2Nq6f3Hedj7ewB,2d58ifebGbosy5xc+FRalqE7ybtjdcyxJlW/eckqjJMbUz4XtSo2fFAqlw9fKhJQ1MIe9UGGuwoIQdV9SyFCrQ==,2UNV7KOq4oGjA5+PKsX47KH2oyd+0TIFyhZ1fYl9fAAfbJaKSXYQ/lskq2jK6SGP
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1634892426.427275169940214160
x-content-type-options: nosniff
set-cookie: TS01e85bed=01f0e93131a9ba88e767a6589a402a36afef0dd5c1b25b37687f4766ccecf93f51a8a649dd5fa1da564660200b53cf84b7a9934957; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10

zentaris.com Whois Information

Domain Name: ZENTARIS.COM
Registry Domain ID: 41371509_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-11-10T18:48:41Z
Creation Date: 2000-11-10T09:21:21Z
Registry Expiry Date: 2025-11-10T09:21:21Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS35.DOMAINCONTROL.COM
Name Server: NS36.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-11T00:17:27Z <<<

zentaris.com valuation and analysis